ALCJ — Crossject SA Share Price
0.000.00%
Last trade - 00:00- €75.73m
- €90.57m
- €0.95m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 42.04 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 12.56 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 151.46 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -51.59% | ||
| Return on Equity | -118.32% | ||
| Operating Margin | -2474.2% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | n/a | 0.5 | n/a | 0.91 | 0.95 | 13.51 | 37.55 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Crossject SA is a France-based company that designs and develops medical injection systems. The Company specializes in needle-free, pre-filled, single-use injection systems for intradermal, subcutaneous and intramuscular applications for pharmaceutical companies. Is also has a pipeline and three drugs in the preclinical or clinical phase of research. The Company's products, which are based on well-known injectable drugs (chemicals and biologics), are designed to enhance patients' safety, compliance and comfort. Crossject’s first ZENEO SUPERGENERIC product is expected to reach the market in the year 2015. The Company has industrial partnerships with Hirtenberger and Recipharm.
Directors
- Philippe Monnot CSU
- Patrick Alexandre CMG (57)
- Eric Nemeth NVC
- Henri de Parseval MGB
- Olivier Gire MGB
- Isabelle Liebschuetz MGB
- Patrice Coissac SUB
- Jean-Francois Loumeau SUB
- Yannick Pletan SUB
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- July 24th, 2001
- Public Since
- February 20th, 2014
- No. of Employees
- 110
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 36,763,256
- Address
- Parc Mazen-Sully, DIJON, 21000
- Web
- https://www.crossject.com
- Phone
- +33 380549850
- Auditors
- PricewaterhouseCoopers Audit sro
Upcoming Events for ALCJ
Similar to ALCJ
AbL Diagnostics SA
Euronext - Paris
Affluent Medical SAS
Euronext - Paris
Alpha MOS SA
Euronext - Paris
Amplitude Surgical SA
Euronext - Paris
Biomerieux SA
Euronext - Paris
FAQ
What is the Crossject SA share price?
As of Today at 19:06 UTC, shares in Crossject SA are trading at €2.06. This share price information is delayed by 15 minutes.
How has the Crossject SA share price performed this year?
Shares in Crossject SA last closed at €2.06 and the price had moved by -47.65% over the past 365 days. In terms of relative price strength the Crossject SA share price has underperformed the FTSE Global All Cap Index by -50.85% over the past year.
What are the analyst and broker recommendations for Crossject SA?
The overall consensus recommendation for Crossject SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Crossject SA dividend yield?
Crossject SA does not currently pay a dividend.
Does Crossject SA pay a dividend?
Crossject SA does not currently pay a dividend.
When does Crossject SA next pay dividends?
Crossject SA does not currently pay a dividend.
How do I buy Crossject SA shares?
To buy shares in Crossject SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Crossject SA?
As of the previous close price of €2.06, shares in Crossject SA had a market capitalisation of €75.73m.
Where are Crossject SA shares listed?
Here are the trading details for Crossject SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALCJ
What kind of share is Crossject SA?
Based on an overall assessment of its quality, value and momentum Crossject SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Crossject SA share price forecast for 2024?
The analyst consensus target price for shares in Crossject SA is €4.70. That is 128.16% above the last closing price of €2.06.
Analysts covering Crossject SA currently have a consensus Earnings Per Share (EPS) forecast of -€0.23 for the next financial year.
What is the trend in the Crossject SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Crossject SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -54.46%.
As of the last closing price of €2.06, shares in Crossject SA were trading -48.43% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Crossject SA PE Ratio?
The Crossject SA PE ratio based on its reported earnings over the past 12 months is 42.04. The shares last closed at €2.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Crossject SA?
Crossject SA's management team is headed by:
- Philippe Monnot - CSU
- Patrick Alexandre - CMG
- Eric Nemeth - NVC
- Henri de Parseval - MGB
- Olivier Gire - MGB
- Isabelle Liebschuetz - MGB
- Patrice Coissac - SUB
- Jean-Francois Loumeau - SUB
- Yannick Pletan - SUB